95 related articles for article (PubMed ID: 9613078)
1. [Time-dependent hemodynamic effects of monosan (Isosorbide-5-mononitrate) in anginal patients].
Zholdin BK; Zaslavskaia RM; Zhamankulov KA
Klin Med (Mosk); 1998; 76(4):30-2. PubMed ID: 9613078
[TBL] [Abstract][Full Text] [Related]
2. [Comparative study of retard and non-retard forms of isosorbide-5-mononitrate in coronary patients with stable angina pectoris].
Lupanov VP; Alekseeva IA; Vasil'eva NN; Romasiuk SS; Afanas'eva IuV; Naumov VG
Klin Med (Mosk); 2000; 78(11):36-8. PubMed ID: 11232528
[TBL] [Abstract][Full Text] [Related]
3. [Selection of therapy with nitrates in patients with stable effort angina: results of comparative study of common isosorbide dinitrate and long acting preparation of isosorbide-5-mononitrate].
Martsevich SIu; Semenova IuE; Alimova EV; Dmitrieva nA; Kozyreva MP; Koniakhina IP; Lukina IuV; Egorov VA
Kardiologiia; 2005; 45(11):42-5. PubMed ID: 16353064
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of the anti-angina effect and effect duration of isosorbide dinitrate, isosorbide-2-mononitrate (IS-2-MN) and isosorbide-5-mononitrate (IS-5-MN)].
Reifart N; Reifart F; Kaltenbach M; Bussmann WD
Med Welt; 1981 Apr; 32(14A):524-6. PubMed ID: 7242313
[No Abstract] [Full Text] [Related]
5. [Efficacy of isosorbide-5-mononitrate retard in patients with stable exertional angina].
Demin AA; Aksenova EA
Klin Med (Mosk); 2005; 83(9):53-6. PubMed ID: 16279042
[TBL] [Abstract][Full Text] [Related]
6. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
Thadani U
Z Kardiol; 1985; 74 Suppl 4():21-4. PubMed ID: 4096067
[TBL] [Abstract][Full Text] [Related]
7. [The anti-anginal efficacy of the drug forms of isosorbide-5-mononitrate--Monocinque, Monocinque retard and isosorbide dinitrate].
Chernov SA; Tiurin VP; Gospodarenko AL; Kutepov IuS; Virs EA; Malenik OM
Voen Med Zh; 1997 Apr; 318(4):39-41. PubMed ID: 9221593
[No Abstract] [Full Text] [Related]
8. [Effects of isosorbide-5-mononitrate on clinical condition, bicycle ergometry results, endothelium-dependent vasodilation in patients with ischemic heart disease with stable effort angina].
Kazachkina SS; Balakhonova TV; Lupanov VP; Pogorelova OA; Rogoza AN; Naumov VG
Ter Arkh; 2005; 77(10):71-5. PubMed ID: 16320691
[TBL] [Abstract][Full Text] [Related]
9. [The therapeutic and prophylactic use of Olicard-Retard under outpatient polyclinical conditions in stenocardia patients].
Mikhaĭlusova MP; Bart BIa; Kulikov SI; Smirnova OL; Anchipolovskaia NG; Mamtsev BN; Dergunova EN
Ter Arkh; 1997; 69(1):17-20. PubMed ID: 9163041
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of dinitrate isosorbide retard forms in ischemic heart disease patients with stable effort angina].
Lupanov VP; Alekseeva IA; Vasil'eva NN; Komar OA; Romasiuk SS; Naumov VG
Ter Arkh; 2000; 72(9):33-6. PubMed ID: 11076413
[TBL] [Abstract][Full Text] [Related]
11. [Delayed-action isosorbide-5-mononitrate preparations--are there differences in the acute effect?].
Jansen W; Geppert R; Weidmann B; Tauchert M
Med Klin (Munich); 1987 Nov; 82(24):854-9. PubMed ID: 3431518
[No Abstract] [Full Text] [Related]
12. Comments on 'A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily and isosorbide dinitrate twice daily in patients with stable angina'.
Nyberg G
Int J Cardiol; 1997 Jun; 60(1):107-10. PubMed ID: 9209948
[No Abstract] [Full Text] [Related]
13. [Hemodynamic effects of isosorbide-5-mononitrate at rest and during exertion in patients with serious angina pectoris].
Biamino G; Oeff M; Andresen D; Lichey HJ; Prokein E; Arntz R; von Leitner E; Schröder R
Med Welt; 1981 Apr; 32(14A):535-9. PubMed ID: 7242316
[No Abstract] [Full Text] [Related]
14. [The effect on painful and silent myocardial ischemia of the preparations Efox and Efox Long in patients with stenocardia of effort].
Belousov IuB; Egorova NA; Karasev AV; Upnitskiĭ AA
Ter Arkh; 1997; 69(9):45-7. PubMed ID: 9411825
[TBL] [Abstract][Full Text] [Related]
15. [Comparative study of isosorbide dinitrates and mononitrates in patients with ischemic heart disease and stable angina pectoris caused by stenosing coronary atherosclerosis].
Lupanov VP; Alekseeva IA; Vasil'eva NN; Chotchaev KhKh; Naumov VG
Klin Med (Mosk); 2000; 78(9):52-5. PubMed ID: 11051743
[TBL] [Abstract][Full Text] [Related]
16. A sustained release formulation of isosorbide-5-mononitrate with a rapid onset of action.
Arthur RM; Mehmel H
Int J Clin Pract; 1999; 53(3):205-12. PubMed ID: 10665134
[TBL] [Abstract][Full Text] [Related]
17. Influence of isosorbide-5-mononitrate on the circadian rhythm of angina pectoris.
Ganzinger U
Arzneimittelforschung; 1992 Mar; 42(3):307-10. PubMed ID: 1497689
[TBL] [Abstract][Full Text] [Related]
18. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
Parker JO
Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
[TBL] [Abstract][Full Text] [Related]
19. [Comparative efficacy, safety, cardio-hemodynamic effects of isosorbide dinitrate (ID) aerosol and sublingual tablets of nitroglycerin].
Ol'binskaia LI; Sizova ZhM; Ushakova AV
Ter Arkh; 1998; 70(5):69-72. PubMed ID: 9644750
[TBL] [Abstract][Full Text] [Related]
20. [Administration of various dosages of retard isosorbide-5-mononitrate in patients with stable angina pectoris on combined therapy].
Chernova EV; Kuchinskaia NG; Barysheva OV; Bezborodova IuV; Shatukhina EIu; Aleshin OI
Klin Med (Mosk); 2002; 80(1):55-7. PubMed ID: 11855323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
